Výsledky vyhledávání - "Jonathan A. Gelfond"

Akademický článek

Increasing and sustaining discharges by noon – a multi-year process improvement project

Autor: Ryan Bailey, Ankur Segon, Sean Garcia, Saket Kottewar, Ting Lu, Nelson Tuazon, Lisa Sanchez, Jonathan A. Gelfond, Gregory Bowling

Publikováno v: BMC Health Services Research, Vol 24, Iss 1, Pp 1-10 (2024)

Abstract High hospital occupancy degrades emergency department performance by increasing wait times, decreasing patient satisfaction, and increasing patient morbidity and mortality. Late discharges contribute to high hospital occupancy by increasing

Externí odkaz: https://doaj.org/article/cc9429445e7e43d9b190fc329ace18e9

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials

Autor: Jonathan A. Gelfond, Brian Hernandez, Martin Goros, Joseph G. Ibrahim, Ming-Hui Chen, Wei Sun, Robin J. Leach, Michael W. Kattan, Ian M. Thompson, Donna Pauler Ankerst, Michael Liss

Publikováno v: BMC Urology, Vol 22, Iss 1, Pp 1-9 (2022)

Abstract Background A model was built that characterized effects of individual factors on five-year prostate cancer (PCa) risk in the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial (PLCO) and the Selenium and Vitamin E Cancer Prevention Tr

Externí odkaz: https://doaj.org/article/e3c167d5bb1e4f05be3968898b2a8a2b

Zobrazit plný text záznamu

Data from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer

Autor: Robert S. Svatek, Tyler J. Curiel, Jonathan A. Gelfond, David J. McConkey, Joshua J. Meeks, Ryan M. Reyes, Zhen-Ju Shu, Neelam Mukherjee, Niannian Ji

Bacillus Calmette-Guérin (BCG) is the most effective intravesical agent at reducing recurrence for patients with high-grade, non–muscle-invasive bladder cancer. Nevertheless, response to BCG is variable and strategies to boost BCG efficacy have no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398ef09ca540566bd7183bee88f85daa
https://doi.org/10.1158/2326-6066.c.6550607.v1

Zobrazit plný text záznamu

Data from Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells

Autor: Tyler J. Curiel, Vincent Hurez, Aijie Liu, Jonathan A. Gelfond, Robert S. Svatek, Srilakshmi Pandeswara, Yang Liu, Vinh Dao

The FDA-approved mTOR inhibitor rapamycin mediates important immune effects, but its contributions to the anticancer effects of the drug are unclear. Here we report evidence that rapamycin-mediated cancer protection relies upon stimulation of γδ T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e810a13e5c9446b743eea300fba41db7
https://doi.org/10.1158/0008-5472.c.6508521.v1

Zobrazit plný text záznamu

supplemental figures combined from Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells

Autor: Tyler J. Curiel, Vincent Hurez, Aijie Liu, Jonathan A. Gelfond, Robert S. Svatek, Srilakshmi Pandeswara, Yang Liu, Vinh Dao

S1 shows DMBA/TPA modulation of epidermal alphabeta and gammadelta TCRhi T cells in WT and CXCR3-/- mice. S2 shows epidermal chemokines in WT and IFN-gamma-/- mice treated with Eudragit control or eRapa. S3 shows mTOR signaling in epidermal and drain

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f37592381d87b3048e2594a572742c
https://doi.org/10.1158/0008-5472.22412790.v1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání